Chapter 7 Nuclear Receptor Repression. Regulatory Mechanisms and Physiological Implications

Progress in Molecular Biology and Translational Science

Volumn 87, Issue C, 2009, Pages 235-259

  Stewart, M David ^a   Wong, Jiemin ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b EAST CHINA NORMAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; REPRESSOR PROTEIN;

ANIMAL; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; METABOLISM; PHYSIOLOGICAL PROCESS; REVIEW;

ANIMALS; GENE EXPRESSION REGULATION; HUMANS; PHYSIOLOGICAL PHENOMENA; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REPRESSOR PROTEINS; TRANSCRIPTION, GENETIC;

EID: 77957029374     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1877-1173(09)87007-5     Document Type: Review

References (111)

1. Baniahmad A., Kohne A.C., and Renkawitz R. A transferable silencing domain is present in the thyroid hormone receptor, in the v-erbA oncogene product and in the retinoic acid receptor. EMBO J 11 (1992) 1015 23
2. Hu X., and Lazar M.A. The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors. Nature 402 (1999) 93 6
3. Nagy L., Kao H.Y., Love J.D., Li C., Banayo E., Gooch J.T., et al. Mechanism of corepressor binding and release from nuclear hormone receptors. Genes Dev 13 (1999) 3209 16
4. Perissi V., Staszewski L.M., McInerney E.M., Kurokawa R., Krones A., Rose D.W., et al. Molecular determinants of nuclear receptor-corepressor interaction. Genes Dev 13 (1999) 3198 208
5. Heery D.M., Kalkhoven E., Hoare S., and Parker M.G. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 387 (1997) 733 6
6. Cavailles V., Dauvois S., L'Horset F., Lopez G., Hoare S., Kushner P.J., et al. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J 14 (1995) 3741 51
7. Ray A., and Prefontaine K.E. Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proc Natl Acad Sci USA 91 (1994) 752 6
8. Scheinman R.I., Gualberto A., Jewell C.M., Cidlowski J.A., and Baldwin Jr. A.S. Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors. Mol Cell Biol 15 (1995) 943 53
9. Li J., Wang J., Wang J., Nawaz Z., Liu J.M., Qin J., et al. Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. EMBO J 19 (2000) 4342 50
10. Zhang J., Kalkum M., Chait B.T., and Roeder R.G. The N-CoR-HDAC3 nuclear receptor corepressor complex inhibits the JNK pathway through the integral subunit GPS2. Mol Cell 9 (2002) 611 23
11. Emiliani S., Fischle W., Van Lint C., Al-Abed Y., and Verdin E. Characterization of a human RPD3 ortholog HDAC3. Proc Natl Acad Sci USA 95 (1998) 2795 800
12. Guenther M.G., Barak O., and Lazar M.A. The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3. Mol Cell Biol 21 (2001) 6091 101
13. Yoon H.G., Chan D.W., Huang Z.Q., Li J., Fondell J.D., Qin J., et al. Purification and functional characterization of the human N-CoR complex: the roles of HDAC3, TBL1 and TBLR1. EMBO J 22 (2003) 1336 46
14. Perissi V., Aggarwal A., Glass C.K., Rose D.W., and Rosenfeld M.G. A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors. Cell 116 (2004) 511 26
15. Alland L., Muhle R., Hou Jr. H., Potes J., Chin L., Schreiber-Agus N., et al. Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature 387 (1997) 49-55
16. Heinzel T., Lavinsky R.M., Mullen T.M., Soderstrom M., Laherty C.D., Torchia J., et al. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 387 (1997) 43 8
17. Nagy L., Kao H.Y., Chakravarti D., Lin R.J., Hassig C.A., Ayer D.E., et al. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 89 (1997) 373 80
18. Hassig C.A., Fleischer T.C., Billin A.N., Schreiber S.L., and Ayer D.E. Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell 89 (1997) 341 7
19. Laherty C.D., Yang W.M., Sun J.M., Davie J.R., Seto E., and Eisenman R.N. Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell 89 (1997) 349 56
20. Zhang Y., Iratni R., Erdjument-Bromage H., Tempst P., and Reinberg D. Histone deacetylases and SAP18, a novel polypeptide, are components of a human Sin3 complex. Cell 89 (1997) 357 64
21. Zhang Y., Sun Z.W., Iratni R., Erdjument-Bromage H., Tempst P., Hampsey M., et al. SAP30, a novel protein conserved between human and yeast, is a component of a histone deacetylase complex. Mol Cell 1 (1998) 1021 31
22. Alland L., David G., Shen-Li H., Potes J., Muhle R., Lee H.C., et al. Identification of mammalian Sds3 as an integral component of the Sin3/histone deacetylase corepressor complex. Mol Cell Biol 22 (2002) 2743 50
23. Kasten M.M., Ayer D.E., and Stillman D.J. SIN3-dependent transcriptional repression by interaction with the Mad1 DNA-binding protein. Mol Cell Biol 16 (1996) 4215 21
24. Yang L., Mei Q., Zielinska-Kwiatkowska A., Matsui Y., Blackburn M.L., Benedetti D., et al. An ERG (ets-related gene)-associated histone methyltransferase interacts with histone deacetylases 1/2 and transcription co-repressors mSin3A/B. Biochem J 369 (2003) 651 7
25. Underhill C., Qutob M.S., Yee S.P., and Torchia J. A novel nuclear receptor corepressor complex, N-CoR, contains components of the mammalian SWI/SNF complex and the corepressor KAP-1. J Biol Chem 275 (2000) 40463 70
26. Dressel U., Thormeyer D., Altincicek B., Paululat A., Eggert M., Schneider S., et al. Alien, a highly conserved protein with characteristics of a corepressor for members of the nuclear hormone receptor superfamily. Mol Cell Biol 19 (1999) 3383 94
27. Altincicek B., Tenbaum S.P., Dressel U., Thormeyer D., Renkawitz R., and Baniahmad A. Interaction of the corepressor Alien with DAX-1 is abrogated by mutations of DAX-1 involved in adrenal hypoplasia congenita. J Biol Chem 275 (2000) 7662 7
28. Polly P., Herdick M., Moehren U., Baniahmad A., Heinzel T., and Carlberg C. VDR-Alien: a novel, DNA-selective vitamin D(3) receptor-corepressor partnership. FASEB J 14 (2000) 1455 63
29. Moehren U., Papaioannou M., Reeb C.A., Hong W., and Baniahmad A. Alien interacts with the human androgen receptor and inhibits prostate cancer cell growth. Mol Endocrinol 21 (2007) 1039 48
30. Lykke-Andersen K., Schaefer L., Menon S., Deng X.W., Miller J.B., and Wei N. Disruption of the COP9 signalosome Csn2 subunit in mice causes deficient cell proliferation, accumulation of p53 and cyclin E, and early embryonic death. Mol Cell Biol 23 (2003) 6790 7
31. Moehren U., Dressel U., Reeb C.A., Vaisanen S., Dunlop T.W., Carlberg C., et al. The highly conserved region of the co-repressor Sin3A functionally interacts with the co-repressor Alien. Nucleic Acids Res 32 (2004) 2995-3004
32. Eckey M., Hong W., Papaioannou M., and Baniahmad A. The nucleosome assembly activity of NAP1 is enhanced by Alien. Mol Cell Biol 27 (2007) 3557 68
33. Li J., Lin Q., Yoon H.G., Huang Z.Q., Strahl B.D., Allis C.D., et al. Involvement of histone methylation and phosphorylation in regulation of transcription by thyroid hormone receptor. Mol Cell Biol 22 (2002) 5688 97
34. Fang S., Miao J., Xiang L., Ponugoti B., Treuter E., and Kemper J.K. Coordinated recruitment of histone methyltransferase G9a and other chromatin-modifying enzymes in SHP-mediated regulation of hepatic bile acid metabolism. Mol Cell Biol 27 (2007) 1407 24
35. Shi Y., Lan F., Matson C., Mulligan P., Whetstine J.R., Cole P.A., et al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119 (2004) 941 53
36. Metzger E., Wissmann M., Yin N., Muller J.M., Schneider R., Peters A.H., et al. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature 437 (2005) 436 9
37. Yokoyama A., Takezawa S., Schule R., Kitagawa H., and Kato S. Transrepressive function of TLX requires the histone demethylase LSD1. Mol Cell Biol 28 (2008) 3995-4003
38. Augereau P., Badia E., Balaguer P., Carascossa S., Castet A., Jalaguier S., et al. Negative regulation of hormone signaling by RIP140. J Steroid Biochem Mol Biol 102 (2006) 51 9
39. Lopez G.N., Webb P., Shinsako J.H., Baxter J.D., Greene G.L., and Kushner P.J. Titration by estrogen receptor activation function-2 of targets that are downstream from coactivators. Mol Endocrinol 13 (1999) 897-909
40. Wei L.N., Hu X., Chandra D., Seto E., and Farooqui M. Receptor-interacting protein 140 directly recruits histone deacetylases for gene silencing. J Biol Chem 275 (2000) 40782 7
41. Christian M., Tullet J.M., and Parker M.G. Characterization of four autonomous repression domains in the corepressor receptor interacting protein 140. J Biol Chem 279 (2004) 15645 51
42. Leonardsson G., Steel J.H., Christian M., Pocock V., Milligan S., Bell J., et al. Nuclear receptor corepressor RIP140 regulates fat accumulation. Proc Natl Acad Sci USA 101 (2004) 8437 42
43. White R., Leonardsson G., Rosewell I., Ann Jacobs M., Milligan S., and Parker M. The nuclear receptor co-repressor nrip1 (RIP140) is essential for female fertility. Nat Med 6 (2000) 1368 74
44. Fernandes I., Bastien Y., Wai T., Nygard K., Lin R., Cormier O., et al. Ligand-dependent nuclear receptor corepressor LCoR functions by histone deacetylase-dependent and -independent mechanisms. Mol Cell 11 (2003) 139 50
45. Sewalt R.G., Gunster M.J., van der Vlag J., Satijn D.P., and Otte A.P. C-Terminal binding protein is a transcriptional repressor that interacts with a specific class of vertebrate Polycomb proteins. Mol Cell Biol 19 (1999) 777 87
46. Potter G.B., Beaudoin III G.M., DeRenzo C.L., Zarach J.M., Chen S.H., and Thompson C.C. The hairless gene mutated in congenital hair loss disorders encodes a novel nuclear receptor corepressor. Genes Dev 15 (2001) 2687 701
47. Potter G.B., Zarach J.M., Sisk J.M., and Thompson C.C. The thyroid hormone-regulated corepressor hairless associates with histone deacetylases in neonatal rat brain. Mol Endocrinol 16 (2002) 2547 60
48. Hsieh J.C., Sisk J.M., Jurutka P.W., Haussler C.A., Slater S.A., Haussler M.R., et al. Physical and functional interaction between the vitamin D receptor and hairless corepressor, two proteins required for hair cycling. J Biol Chem 278 (2003) 38665 74
49. Moraitis A.N., Giguere V., and Thompson C.C. Novel mechanism of nuclear receptor corepressor interaction dictated by activation function 2 helix determinants. Mol Cell Biol 22 (2002) 6831 41
50. Chatterjee V.K., Lee J.K., Rentoumis A., and Jameson J.L. Negative regulation of the thyroid-stimulating hormone alpha gene by thyroid hormone: receptor interaction adjacent to the TATA box. Proc Natl Acad Sci USA 86 (1989) 9114 8
51. Coser K.R., Chesnes J., Hur J., Ray S., Isselbacher K.J., and Shioda T. Global analysis of ligand sensitivity of estrogen inducible and suppressible genes in MCF7/BUS breast cancer cells by DNA microarray. Proc Natl Acad Sci USA 100 (2003) 13994 9
52. Yen P.M., Feng X., Flamant F., Chen Y., Walker R.L., Weiss R.E., et al. Effects of ligand and thyroid hormone receptor isoforms on hepatic gene expression profiles of thyroid hormone receptor knockout mice. EMBO Rep 4 (2003) 581 7
53. Liu Y.Y., and Brent G.A. Thyroid hormone-dependent gene expression in differentiated embryonic stem cells and embryonal carcinoma cells: identification of novel thyroid hormone target genes by deoxyribonucleic acid microarray analysis. Endocrinology 146 (2005) 776 83
54. Galon J., Franchimont D., Hiroi N., Frey G., Boettner A., Ehrhart-Bornstein M., et al. Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J 16 (2002) 61-71
55. James C.G., Ulici V., Tuckermann J., Underhill T.M., and Beier F. Expression profiling of Dexamethasone-treated primary chondrocytes identifies targets of glucocorticoid signalling in endochondral bone development. BMC Genomics 8 (2007) 205
56. Swami S., Raghavachari N., Muller U.R., Bao Y.P., and Feldman D. Vitamin D growth inhibition of breast cancer cells: gene expression patterns assessed by cDNA microarray. Breast Cancer Res Treat 80 (2003) 49-62
57. Wang T.T., Tavera-Mendoza L.E., Laperriere D., Libby E., MacLeod N.B., Nagai Y., et al. Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol Endocrinol 19 (2005) 2685 95
58. Hollenberg A.N., Monden T., Flynn T.R., Boers M.E., Cohen O., and Wondisford F.E. The human thyrotropin-releasing hormone gene is regulated by thyroid hormone through two distinct classes of negative thyroid hormone response elements. Mol Endocrinol 9 (1995) 540 50
59. Shibusawa N., Hollenberg A.N., and Wondisford F.E. Thyroid hormone receptor DNA binding is required for both positive and negative gene regulation. J Biol Chem 278 (2003) 732 8
60. Ortiga-Carvalho T.M., Shibusawa N., Nikrodhanond A., Oliveira K.J., Machado D.S., Liao X.H., et al. Negative regulation by thyroid hormone receptor requires an intact coactivator-binding surface. J Clin Invest 115 (2005) 2517 23
61. Wulf A., Wetzel M.G., Kebenko M., Kroger M., Harneit A., Merz J., et al. The role of thyroid hormone receptor DNA binding in negative thyroid hormone-mediated gene transcription. J Mol Endocrinol 41 (2008) 25-34
62. Wang D., Xia X., Liu Y., Oetting A., Walker R.L., Zhu Y., et al. Negative regulation of TSH{alpha} target gene by thyroid hormone involves histone acetylation and corepressor complex dissociation. Mol Endocrinol 23 (2009) 600 9
63. Murayama A., Kim M.S., Yanagisawa J., Takeyama K., and Kato S. Transrepression by a liganded nuclear receptor via a BHLH activator through co-regulator switching. EMBO J 23 (2004) 1598 608
64. Kato S., Fujiki R., Kim M.S., and Kitagawa H. Ligand-induced transrepressive function of VDR requires a chromatin remodeling complex, WINAC. J Steroid Biochem Mol Biol 103 (2007) 372 80
65. Cvoro A., Tzagarakis-Foster C., Tatomer D., Paruthiyil S., Fox M.S., and Leitman D.C. Distinct roles of unliganded and liganded estrogen receptors in transcriptional repression. Mol Cell 21 (2006) 555 64
66. Garcia-Ramirez M., Rocchini C., and Ausio J. Modulation of chromatin folding by histone acetylation. J Biol Chem 270 (1995) 17923 8
67. Tse C., Sera T., Wolffe A.P., and Hansen J.C. Disruption of higher-order folding by core histone acetylation dramatically enhances transcription of nucleosomal arrays by RNA polymerase III. Mol Cell Biol 18 (1998) 4629 38
68. Wang X., and Hayes J.J. Acetylation mimics within individual core histone tail domains indicate distinct roles in regulating the stability of higher-order chromatin structure. Mol Cell Biol 28 (2008) 227 36
69. Cary P.D., Crane-Robinson C., Bradbury E.M., and Dixon G.H. Effect of acetylation on the binding of N-terminal peptides of histone H4 to DNA. Eur J Biochem 127 (1982) 137 43
70. Hong L., Schroth G.P., Matthews H.R., Yau P., and Bradbury E.M. Studies of the DNA binding properties of histone H4 amino terminus. Thermal denaturation studies reveal that acetylation markedly reduces the binding constant of the H4 "tail" to DNA. J Biol Chem 268 (1993) 305 14
71. Dhalluin C., Carlson J.E., Zeng L., He C., Aggarwal A.K., and Zhou M.M. Structure and ligand of a histone acetyltransferase bromodomain. Nature 399 (1999) 491 6
72. Chen D., Ma H., Hong H., Koh S.S., Huang S.M., Schurter B.T., et al. Regulation of transcription by a protein methyltransferase. Science 284 (1999) 2174 7
73. Koh S.S., Chen D., Lee Y.H., and Stallcup M.R. Synergistic enhancement of nuclear receptor function by p160 coactivators and two coactivators with protein methyltransferase activities. J Biol Chem 276 (2001) 1089 98
74. Wang H., Huang Z.Q., Xia L., Feng Q., Erdjument-Bromage H., Strahl B.D., et al. Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor. Science 293 (2001) 853 7
75. Goo Y.H., Sohn Y.C., Kim D.H., Kim S.W., Kang M.J., Jung D.J., et al. Activating signal cointegrator 2 belongs to a novel steady-state complex that contains a subset of trithorax group proteins. Mol Cell Biol 23 (2003) 140 9
76. Lee S., Lee D.K., Dou Y., Lee J., Lee B., Kwak E., et al. Coactivator as a target gene specificity determinant for histone H3 lysine 4 methyltransferases. Proc Natl Acad Sci USA 103 (2006) 15392 7
77. Boulias K., and Talianidis I. Functional role of G9a-induced histone methylation in small heterodimer partner-mediated transcriptional repression. Nucleic Acids Res 32 (2004) 6096 103
78. Hwang C., Giri V.N., Wilkinson J.C., Wright C.W., Wilkinson A.S., Cooney K.A., et al. EZH2 regulates the transcription of estrogen-responsive genes through association with REA, an estrogen receptor corepressor. Breast Cancer Res Treat 107 (2008) 235 42
79. Shi B., Liang J., Yang X., Wang Y., Zhao Y., Wu H., et al. Integration of estrogen and Wnt signaling circuits by the polycomb group protein EZH2 in breast cancer cells. Mol Cell Biol 27 (2007) 5105 19
80. Shi Y.J., Matson C., Lan F., Iwase S., Baba T., and Shi Y. Regulation of LSD1 histone demethylase activity by its associated factors. Mol Cell 19 (2005) 857 64
81. Garcia-Bassets I., Kwon Y.S., Telese F., Prefontaine G.G., Hutt K.R., Cheng C.S., et al. Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors. Cell 128 (2007) 505 18
82. Alenghat T., Yu J., and Lazar M.A. The N-CoR complex enables chromatin remodeler SNF2H to enhance repression by thyroid hormone receptor. EMBO J 25 (2006) 3966 74
83. Kemper J.K., Kim H., Miao J., Bhalla S., and Bae Y. Role of an mSin3A-Swi/Snf chromatin remodeling complex in the feedback repression of bile acid biosynthesis by SHP. Mol Cell Biol 24 (2004) 7707 19
84. Ewing A.K., Attner M., and Chakravarti D. Novel regulatory role for human Acf1 in transcriptional repression of vitamin D3 receptor-regulated genes. Mol Endocrinol 21 (2007) 1791 806
85. de The H., Lavau C., Marchio A., Chomienne C., Degos L., and Dejean A. The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66 (1991) 675 84
86. Kakizuka A., Miller Jr. W.H., Umesono K., Warrell Jr. R.P., Frankel S.R., Murty V., et al. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell 66 (1991) 663 74
87. Hong S.H., David G., Wong C.W., Dejean A., and Privalsky M.L. SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor alpha (RARalpha) and PLZF-RARalpha oncoproteins associated with acute promyelocytic leukemia. Proc Natl Acad Sci USA 94 (1997) 9028 33
88. Guidez F., Ivins S., Zhu J., Soderstrom M., Waxman S., and Zelent A. Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia. Blood 91 (1998) 2634 42
89. Di Croce L., Raker V.A., Corsaro M., Fazi F., Fanelli M., Faretta M., et al. Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science 295 (2002) 1079 82
90. Kiskinis E., Hallberg M., Christian M., Olofsson M., Dilworth S.M., White R., et al. RIP140 directs histone and DNA methylation to silence Ucp1 expression in white adipocytes. EMBO J 26 (2007) 4831 40
91. Meissner A., Mikkelsen T.S., Gu H., Wernig M., Hanna J., Sivachenko A., et al. Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 454 (2008) 766 70
92. Refetoff S. Resistance to thyroid hormone. Clin Lab Med 13 (1993) 563 81
93. Sap J., Munoz A., Damm K., Goldberg Y., Ghysdael J., Leutz A., et al. The c-erb-A protein is a high-affinity receptor for thyroid hormone. Nature 324 (1986) 635 40
94. Weinberger C., Thompson C.C., Ong E.S., Lebo R., Gruol D.J., and Evans R.M. The c-erb-A gene encodes a thyroid hormone receptor. Nature 324 (1986) 641 6
95. Lee S., and Privalsky M.L. Multiple mutations contribute to repression by the v-Erb A oncoprotein. Oncogene 24 (2005) 6737 52
96. Sachs L.M., Damjanovski S., Jones P.L., Li Q., Amano T., Ueda S., et al. Dual functions of thyroid hormone receptors during Xenopus development. Comp Biochem Physiol B Biochem Mol Biol 126 (2000) 199-211
97. Sachs L.M., Jones P.L., Havis E., Rouse N., Demeneix B.A., and Shi Y.B. Nuclear receptor corepressor recruitment by unliganded thyroid hormone receptor in gene repression during Xenopus laevis development. Mol Cell Biol 22 (2002) 8527 38
98. Tomita A., Buchholz D.R., and Shi Y.B. Recruitment of N-CoR/SMRT-TBLR1 corepressor complex by unliganded thyroid hormone receptor for gene repression during frog development. Mol Cell Biol 24 (2004) 3337 46
99. Buchholz D.R., Hsia S.C., Fu L., and Shi Y.B. A dominant-negative thyroid hormone receptor blocks amphibian metamorphosis by retaining corepressors at target genes. Mol Cell Biol 23 (2003) 6750 8
100. Paul B.D., Fu L., Buchholz D.R., and Shi Y.B. Coactivator recruitment is essential for liganded thyroid hormone receptor to initiate amphibian metamorphosis. Mol Cell Biol 25 (2005) 5712 24
101. Buchholz D.R., Tomita A., Fu L., Paul B.D., and Shi Y.B. Transgenic analysis reveals that thyroid hormone receptor is sufficient to mediate the thyroid hormone signal in frog metamorphosis. Mol Cell Biol 24 (2004) 9026 37
102. Sato Y., Buchholz D.R., Paul B.D., and Shi Y.B. A role of unliganded thyroid hormone receptor in postembryonic development in Xenopus laevis. Mech Dev 124 (2007) 476 88
103. Barak Y., Nelson M.C., Ong E.S., Jones Y.Z., Ruiz-Lozano P., Chien K.R., et al. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell 4 (1999) 585 95
104. Akiyama T.E., Sakai S., Lambert G., Nicol C.J., Matsusue K., Pimprale S., et al. Conditional disruption of the peroxisome proliferator-activated receptor gamma gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux. Mol Cell Biol 22 (2002) 2607 19
105. Koutnikova H., Cock T.A., Watanabe M., Houten S.M., Champy M.F., Dierich A., et al. Compensation by the muscle limits the metabolic consequences of lipodystrophy in PPAR gamma hypomorphic mice. Proc Natl Acad Sci USA 100 (2003) 14457 62
106. Picard F., Kurtev M., Chung N., Topark-Ngarm A., Senawong T., Machado De Oliveira R., et al. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 429 (2004) 771 6
107. Chen D., Bruno J., Easlon E., Lin S.J., Cheng H.L., Alt F.W., et al. Tissue-specific regulation of SIRT1 by calorie restriction. Genes Dev 22 (2008) 1753 7
108. Yu C., Markan K., Temple K.A., Deplewski D., Brady M.J., and Cohen R.N. The nuclear receptor corepressors NCoR and SMRT decrease peroxisome proliferator-activated receptor gamma transcriptional activity and repress 3T3-L1 adipogenesis. J Biol Chem 280 (2005) 13600 5
109. Astapova I., Lee L.J., Morales C., Tauber S., Bilban M., and Hollenberg A.N. The nuclear corepressor, NCoR, regulates thyroid hormone action in vivo. Proc Natl Acad Sci USA 105 (2008) 19544 9
110. Nofsinger R.R., Li P., Hong S.H., Jonker J.W., Barish G.D., Ying H., et al. SMRT repression of nuclear receptors controls the adipogenic set point and metabolic homeostasis. Proc Natl Acad Sci USA 105 (2008) 20021 6
111. Smith C.L., Nawaz Z., and O'Malley B.W. Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen. Mol Endocrinol 11 (1997) 657 66